News
As the government bans smoking in public places, the situation at educational institutions doesn’t look too good ...
Pre-Clinical Drug Discovery Services Market to grow through 2035, driven by rising chronic diseases and increased outsourcing of early-stage R&D.
The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced ...
Boehringer Ingelheim unveiled new data from its top oncology prospect zongertinib, further backing the drug’s prowess in ...
Veteran actress Sharmila Tagore's early-stage lung cancer diagnosis has brought attention to zero-stage lung cancer, also known as carcinoma in situ. Discovered during a routine check, this pre ...
Cindy was a healthy, 35-year-old woman with no symptoms of cancer when she joined the American Lung Association’s Lung Health Cohort Study.
Lung cancer is the leading cause of cancer-related death in the U.S. This makes lung cancer screening important.
9h
News-Medical.Net on MSNTargeted drug zongertinib shows strong results for HER2-mutant lung cancer in clinical trialThe HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced HER2-mutant non-small cell lung cancer – particularly those with specific HER2 ...
Although immunotherapies and biomarker-driven interventions have transformed lung cancer outcomes, Martin Edelman, MD, Fox Chase Cancer Center, highlighted the present challenge hindering clinicians' ...
Rory Londer's third "walk of gratitude" around the Mayo Clinic campus coincides with an expansion of support services for ...
Adults eligible for both breast or colorectal cancer screening and lung cancer screening are less likely to be screened for lung cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results